Relay Therapeutics Statistics
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
16.12+0.21 (+1.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Relay Therapeutics by the numbers
Relay Therapeutics has a market capitalization of $3.56 billion based on 220.96M shares outstanding. With trailing EPS of $-1.50, Relay Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.1% below its 50-day average and 2.4% above its 200-day average.
Average daily trading volume is 2.93M shares, or about $47.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RLAY valuation vs. peer median
| Metric | RLAY | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.56B | $3.07B | +16% |
| Avg. volume | 2.93M | 1.89M | +55% |
Peer median across 8 companies: TARS, CRSP, IOVA, DNLI, VCEL, ADMA, ADPT, BEAM.
Valuation
- Market cap
- $3.56B
- Price / sales (latest FY)
- 231.97
- EPS (TTM)
- $-1.50
- Shares outstanding
- 220.96M
Price and trading
- Previous close
- 15.91
- Open
- 15.59
- Day range
- 15.17 – 16.32
- 52-week range
- 6.80 – 21.27
- 52-week change
- +138.11%
- Beta
- —
- Volume
- 3.98M
- Average volume
- 2.93M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 3.56B
- Forward Pe
- -10.26
- Eps
- -1.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.27
- Week52 Low
- 6.80
- Avg Volume
- 2.93M
- Shares Outstanding
- 220.96M
- Ma50
- 18.13
- Ma200
- 15.74
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -24.21%
- Pct From52w Low
- 137.06%